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Abstract
Background: We describe the epidemiology of hospitalized RSV infections for all age groups from population-based
surveillance in two rural provinces in Thailand.
Methods: From September 1, 2003 through December 31, 2007, we enrolled hospitalized patients with acute lower
respiratory tract illness, who had a chest radiograph ordered by the physician, from all hospitals in SaKaeo and Nakhom
Phanom Provinces. We tested nasopharyngeal specimens for RSV with reverse transcriptase polymerase chain reaction (RT-
PCR) assays and paired-sera from a subset of patients with IgG enzyme immunoassay. Rates were adjusted for enrollment.
Results: Among 11,097 enrolled patients, 987 (8.9%) had RSV infection. Rates of hospitalized RSV infection overall (and
radiographically-confirmed pneumonia) were highest among children aged ,1 year: 1,067/100,000 (534/100,000
radiographically-confirmed pneumonia) and 1–4 year: 403/100,000 (222/100,000), but low among enrolled adults aged
$65 years: 42/100,000. Age ,1 year (adjusted odds ratio [aOR] =13.2, 95% confidence interval [CI] 7.7, 22.5) and 1–4 year
(aOR=8.3, 95% CI 5.0, 13.9) were independent predictors of hospitalized RSV infection.
Conclusions: The incidence of hospitalized RSV lower respiratory tract illness among children ,5 years was high in rural
Thailand. Efforts to prevent RSV infection could substantially reduce the pneumonia burden in children aged ,5 years.
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Introduction
Respiratory syncytial virus (RSV) is the most common cause of
hospitalized respiratory illness among children ,5 years of age in
industrialized countries and a common pathogen identified among
hospitalized children in developing countries[1,2,3,4,5].While
RSV infection is also associated with a large burden of illness
that can be managed in outpatient facilities [1], those that are
severe enough to require hospitalization are most worrisome.
Severe lower respiratory syndromes associated with RSV infection
include pneumonia and bronchiolitis. Pneumonia is the leading
cause of childhood mortality among children ,5 years of age in all
regions of the world, responsible for an estimated 19% of all deaths
in this age group [6]. RSV has been reported to account for 5–
40% of pediatric hospitalized pneumonia [7,8,9,10].
In 2003, active surveillance for hospitalized pneumonia was
initiated in two provinces in Thailand, Sa Kaeo and Nakhon
Phanom provinces, with the goal of detecting and describing the
burden and characteristics of pathogens causing pneumonia[11].
In Thailand, a middle income tropical country, information on
disease burden is needed inform pneumonia treatment and
prevention strategies. In addition, epidemiologic characteristics
of pneumonia in Thailand may be applicable to other Asian
tropical countries that lack the infrastructure for active case finding
and cutting edge diagnostics. We describe the incidence,
epidemiology, and clinical characteristics of patients hospitalized
RSV infections, including radiographically-confirmed pneumonia,
for all age groups from population-based surveillance in two rural
provinces in Thailand during 2004 through 2007. In addition, we
describe a new sensitive RSV real time reverse transcriptase
polymerase chain reaction (rRT-PCR) assay for RSV.
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RT-PCR Assays
RT-PCR assays used in this study to test for RSV included: 1)
an automated fluorescent capillary electrophoresis-based RT-PCR
(fceRT-PCR)[12] used to test samples collected prior to Septem-
ber 1, 2005; 2) a newly developed rRT-PCR described here used
to test samples collected during subsequent years (see Text S1 for
methods and validation); 3) an RT-PCR assay[13] used to
distinguish RSV groups A and B in positive samples from Sa
Kaeo Province from Sept 1, 2003 – Aug 31, 2005 (see Text S1). In
addition, we tested for human metapneumovirus (HMPV), human
parainfluenza viruses (HPIV) serotypes 1, 2, and 3, adenovirus,
and influenza viruses type A and B using RT-PCR assays that will
be described elsewhere [14].
Study design, specimen collection, and data analysis
A detailed description of the population-based surveillance
system for clinical pneumonia in all eight hospitals in Sa Kaeo
Province and all 12 hospitals in Nakhon Phanom Province,
Thailand has been published[15]. These two provinces represent
typical rural provinces and border Cambodia and Laos. A study to
determine etiologies among enrolled patients from the clinical
pneumonia surveillance system began September 1, 2003 in Sa
Kaeo and January 1, 2005 in Nakhon Phanom and has been
described in detail[14]. Briefly, a patient was eligible for
enrollment if he/she had at least one sign of acute infection (i.e.,
fever, abnormal white cell count) plus signs or symptoms of lower
respiratory tract disease (i.e., cough, shortness of breath, etc), and
the physician ordered a chest radiograph within 48 hours of
admission. Each enrolled patient had a nasopharyngeal swab,
acute and convalescent sera and clinical and demographic
information collected. We considered repeat hospitalizations that
occurred $14 days after the previous discharge date as individual
hospitalizations. Chest radiographs were read by an expert panel
and determined to be consistent with pneumonia. World Health
standard criteria were used for children and adult criteria have
been described previously [16].
Nasopharyngeal (NP) swabs in viral transport media and acute-
and convalescent-phase serum specimens were collected, trans-
ported, processed and stored as described elsewhere[17]. TNA
extracts from 200 uL of the swab specimens were prepared on the
BioRobot MDx Workstation (Qiagen) and stored at 270uCo r
lower until testing by RT-PCR. Acute- and convalescent-phase
sera were tested for RSV only during September 1, 2003 - August
31, 2005 on specimens from enrolled patients from SaKaeo
Province by indirect IgG enzyme immunoassay as previously
described[18]. A specimen was considered to have a positive viral
result if RT-PCR testing was positive or if there was a four-fold or
greater rise in antibody titer between the acute and convalescent
sera.
We calculated crude and age-specific (,1, 1–4, 5–19, 20–49,
50–64, $65 years) incidence for RSV infections using population
estimates from Thailand’s National Economic and Social
Development Board
18 for the period January 1, 2004 through
December 31, 2007. Because not all patients eligible for our study
chose to participate, we determined a crude incidence and an
estimated adjusted incidence to account for RSV cases in eligible
patients who did not enroll. For the adjusted incidence we
assumed the proportion of RSV infections in the enrolled patients
was the same as the proportion of infections among all eligible
patients; the number of eligible pneumonia patients in each age
group was multiplied by the age-specific proportion of RSV-
infected patients and divided by the population estimates. RSV
infections with other viral co-infections were included in incidence
estimates; we assumed that RSV contributed to illness. Confidence
intervals for adjusted incidence estimates were estimated using the
95% confidence intervals of the proportion of RSV positive tests
assuming a binomial distribution.
We compared characteristics of patients with radiographically-
confirmed pneumonia associated with RSV infections to patients
with radiographically-confirmed pneumonia with negative RSV
testing results. We also compared patients with RSV infection who
had a chest radiograph that was not consistent pneumonia to RSV
negative patients without pneumonia. Dichotomous variables were
compared by chi-square test and included in an unconditional
logistic regression model if p,0.1. Interaction terms and effect
modification were ruled out. All analysis was performed in SAS
(version 9.1, SAS institute, Cary, NC). Two-tailed P values ,0.05
were considered statistically significant. The data set for this
analysis was finalized September 2009.
All participants were informed of the study objectives and
written consent was obtained. This study protocol was reviewed
and approved by the Centers for Disease Control and Prevention
(CDC) Internal Review Board and the Thailand Ministry of Public
Health Internal Review Board.
Results
Study Results
During September 1, 2003 - December 31, 2007, 41,761 patient
admissions were identified with acute lower respiratory tract
disease in Sa Kaeo and Nakhon Phanom Provinces. Of these,
22,857 (55%) received a chest radiograph and were eligible for
enrollment and 11,097 (49%) were enrolled. Among enrolled
patients, 987 (8.9%) had a positive diagnostic test for RSV. During
September 1, 2003 – August 31, 2005, when serology was
performed on specimens from enrolled patients from Sa Kaeo
Province, 44 (25%) of the 175 RSV infections were only detected
by serology. Conversely, 62 (35%) RSV infections were detected
only by RT-PCR and 54 (31%) were detected by both methods.
The proportion of RSV infections only detected by serology was
highest among older children and adults ($65 years 4/8 [50%],
50–64 years: 1/1 [100%], 20–49 years: 3/10 [30%], 5–19 years:
8/15 [53%], 1–4 years: 24/102 [24%], ,1 year: 4/39 [10%]).
Among all enrolled patients, most hospitalized RSV infections
occurred among young children (Table 1, Figure 1). The highest
incidence of hospitalized RSV-associated illness, including radio-
graphically-confirmed pneumonia, was among children aged ,1
year followed by children aged 1–4 years, a consistent finding each
year during the four year period. The adjusted incidence of RSV
illness among all enrolled children ,5 years of age was 507/
100,000 persons per year and the adjusted incidence of RSV
pneumonia was 254/100,000 persons per year. Among enrolled
hospitalized children with acute lower respiratory illness aged ,1
year and from 1–4 years, 22% and 18% were associated with RSV
infection, respectively. RSV accounted for 25% and 21% of all
patients with radiographically-confirmed pneumonia among these
two age groups, respectively. Radiographically- confirmed pneu-
monia accounted for 50% of RSV infections among enrolled
children and 55% of all RSV infections among enrolled children
aged 1–4 years of age. The incidence rates of RSV-associated
illness were low for enrolled adults, including adults $65 years of
age.
Among enrolled children ,5 years of age during 2004 though
2007, infection with RSV was most common among children aged
0–5 months (120/548 [22%]) and 6–11 months (167/741 [23%]).
RSV infection was also common for each subsequent year of age,
RSV Pneumonia in Thailand
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years (68/416 [16%]), and 4 years (36/272 [13%]) of age.
Independent risk factors for RSV infection among patients with
radiographically-confirmed pneumonia included young age
(Table 2). Compared to adults, children ,12 months of age were
11-fold more likely to have RSV pneumonia versus pneumonia
with a negative RSV test. Increased risk for RSV pneumonia was
also notable for children 1–4 and 5–19 years of age. In addition,
documented fever and tachypnea at admission were independent
predictors for RSV infection among pneumonia patients. The
month of patient admission was strongly predictive for RSV
infection; admission during June through October was statistically
associated with RSV pneumonia. We found similar risk factors for
RSV lower respiratory infection with a chest radiograph that was
not consistent pneumonia (RSV infection without pneumonia)
compared to RSV negative patients without pneumonia, except
for tachypnea.
Among the 520 hospitalized patients with radiographically-
confirmed RSV pneumonia, 67 (13%) had signs of consolidation,
413 (79%) had interstitial infiltrates, and 153 (29%) patients had
alveolar infiltrates (no category was mutually exclusive).
Overall, 247 in-hospital deaths were reported for enrolled
hospitalized patients during the four year study period; three
deaths occurred among patients with RSV infection (one in a child
aged 1–4 years and two in adults aged 20–49 year). Among
patients with radiographically-confirmed pneumonia 179 (72%)
deaths occurred, 83 (46%) among persons .65 years, 35 (20%)
among persons 50–64 years, 46 (26%) among persons 20–29 years,
4 (2.2%) among persons 5–19 years, 6 (3.4%) among children 1–4
years and 5 (2.8%) among children ,1 year. One of the 179
pneumonia deaths was associated with RSV infection in a 1-year
old child. Two additional fatalities occurred among patients with
RSV infection without radiographically-confirmed pneumonia,
both were adults 20–49 years of age.
During the period under surveillance, RSV circulation
appeared to peak between June and October (Figure 2). During
2005, when annual RSV circulation was highest, RSV was
detected for most months of the year but peaked between June and
October. During July through October, RSV infection was
detected in 2 to 47% of all enrolled hospitalized patients (all ages)
each month. There was no difference in RSV circulation between
the two provinces.
Among 225 available specimens with a positive RT-PCR test
for RSV, 147 (65%) were group A, 49 (22%) were group B, and 29
(13%) had a negative typing test. During two RSV peak circulation
periods, both group A and B RSV viruses circulated (data not
shown).
There were no differences between patients with group A RSV
infection versus group B infection with regard to fever (A:108
[78%] vs. B:13 [68%]), mechanical ventilation (A:0 vs. B:0), death
(A:0 vs. B:0), or age-specific tachypnea (A:90 [98%] vs. B:12
[67%]). Patients with infection with group B RSV were more likely
to present with wheezing (A:29 [21%] vs. B:10 [52%], Fisher’s
exact p=.008), were more commonly adults $65 years of age (A:2
[1.5%] vs. B:4 [21%]) and less commonly children aged 1–4 years
(A:87 [63%] vs. B:6 [32%], X
2 p=.004). There were no
differences among the other age groups.
Discussion
We demonstrated a substantial burden of RSV-associated
pneumonia among children in two rural Provinces in Thailand
during the study period; 1 in 187 children aged 1–11 months and
1 in 450 children aged 1–4 years were hospitalized annually for
radiographically-confirmed RSV pneumonia. RSV accounted for
25% of hospitalized radiographically-confirmed pneumonia
among children ,1 year of age and 21% among children 1–4
years of age. In addition, RSV caused an almost equal number of
additional hospitalizations among children for lower respiratory
tract illnesses that were not radiographically-proven pneumonia.
Age ,1 year and 1–4 years were strong predictors of RSV-
associated illness. In contrast, ,2% of enrolled adults $65 years of
age had RSV infection.
There are few population-based studies that report rates of
RSV-associated radiographically-confirmed pneumonia. Our ad-
justed rate of RSV radiographically-confirmed pneumonia for all
Table 1. Average crude and adjusted incidence for hospitalized patients with RSV infections, Sa Kaeo and Nakhon Phanom
Provinces, January 1, 2004 – December 31, 2007.
Incidence/100,000 persons per year
Age
group
Enrolled/
Eligible
No./No. (%)
Enrolled
patients with
RSV No. (%
of enrolled)
Enrolled
patients
with CXR
confirmed
pneumonia
No (% of
enrolled)
CXR confirmed
pneumonia
with RSV No
(% of patients
with CXR
pneumonia)
Crude
incidence CXR
confirmed RSV
pneumonia*
Adjusted
incidence CXR
confirmed RSV
pneumonia
(95% CI)
Crude incidence
RSV
hospitalization
among enrolled
patients
Adjusted
incidence RSV
hospitalization
among enrolled
patients (95% CI)
1–11 mo 1313/2723 (49) 294 (22) 601 (46) 148 (25) 257 547 (464, 630) 524 1,087 (977, 1196)
1–4 yrs 2790/5250 (53) 505 (18) 1333 (48) 277 (21) 120 223 (198, 248) 216 406 (374, 438)
5–19 yrs 1069/1954 (55) 55 (5) 387 (36) 25 (6.5) 2.2 4.0 (2.4, 5.5) 4.8 8.7 (6.5, 11)
20–49 yrs 1616/3617 (45) 33 (2) 698 (43) 16 (2.3) 0.8 1.8 (0.9, 2.6) 1.6 3.6 (2.4, 4.9)
50–64 yrs 1509/3034 (50) 24 (2) 651 (43) 12 (1.8) 2.1 4.3 (1.9, 6.8) 4.3 8.6 (5.2, 12)
$65 yrs 2577/5669 (45) 48 (2) 1189 (46) 20 (1.7) 7.5 16 (0.3, 24) 18 39 (28, 50)
Total 10,868/22,247 (49) 959 (9) 4850 (45) 498 (10) 12 24 (22, 26) 22 46 (43, 48)
CXR = chest radiograph, CI = confidence intervals.
*Among patients with radiographically-confirmed RSV pneumonia during January 1, 2004 through December 31, 2007, 46 had co-infections with other viruses,
including one with HPIV1, five with HPIV3, 16 with adenovirus, 15 with influenza A or B viruses, and nine with HMPV. These patients were included in RSV incidence
calculations.
doi:10.1371/journal.pone.0015098.t001
RSV Pneumonia in Thailand
PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15098adults (3.6/100,000) was higher than that reported in the United
States in the 1990s (1.6/100,000); however, we used a more
sensitive assay, RT-PCR[19]. Rates of RSV-associated radio-
graphically-confirmed pneumonia among children have not been
reported from the U.S. or other industrial countries, or from
developing countries. However, our rates of hospitalized lower
respiratory illness (enrolled patients) were similar to rates of
hospitalizations for the clinical syndrome of pneumonia and severe
pneumonia in Kenyan children (children ,1 year: 1107/100,00
and children ,5 year: 293/100,000)[20]. Additional studies to
document rates of RSV disease, including radiographically-
confirmed pneumonia, in developing and industrial countries
Figure 1. Adjusted annual incidence of hospitalized RSV respiratory illness (A) and hospitalized chest radiograph-confirmed RSV
pneumonia (B) by age group, SaKaeo and Nakhon Phanom Provinces, during four consecutive years, January 1, 2004 – December
31, 2007. 2004 data are only from Sa Kaeo Province. Inset shows adjusted incidence values for age groups, 5–19 years, 20–49 years, 50–64 years, and
$65 years.
doi:10.1371/journal.pone.0015098.g001
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confirmed pneumonia and for RSV respiratory illness without pneumonia compared to non-RSV respiratory illness without
pneumonia, Sa Kaeo and Nakhon Phanom Provinces, September 1, 2003– December 31, 2007.
RSV pneumonia vs. non-RSV pneumonia
RSV respiratory illness without pneumonia vs. non-RSV
respiratory illness without pneumonia
Adjusted OR (95% CI) Adjusted OR (95% CI)
Age group
0–11 months
1–4 years
5–19 years
20–49 years
50–64 years
$65 years
11.4 (6.6, 19.8)
8.3 (4.9, 14.1)
2.5 (1.3, 4.8)
Referent
0.8 (0.4, 1.8)
0.8 (0.4, 1.7)
13.2 (7.7, 22.5)
8.3 (5.0, 13.9)
2.3 (1.2, 4.2)
Referent
0.9 (0.4, 1.9)
1.3 (0.7, 2.4)
Temperature $38C 1.7 (1.3, 2.2) 2.6 (2.0, 3.3)
Tachypnea* 1.4 (1.1, 1.8) 1.1 (0.8, 1.5)
Wheezing 0.8 (0.6, 1.0) 1.0 (0.8, 1.2)
Month of admission
January
February
March
April
May
June
July
August
September
October
November
December
1.9 (0.6, 5.8)
1.4 (0.5, 4.0)
1.2 (0.4, 3.5)
1.2 (0.4, 4.0)
2.1 (0.7, 7.4)
11.4 (4.4,29)
21.3 (8.4, 53.8)
12.0 (4.8, 30.5)
9.4 (3.7, 23.8)
4.7 (1.8, 12.4)
2.4 (0.9, 7.1)
Referent
1.2 (0.2, 7.1)
2.7 (0.6, 12.6)
1.9 (0.4, 9.2)
3.4 (0.7, 16.9)
4.4 (0.9, 20.3)
13.1 (3.1, 55.0)
37.2 (9.1, 153.3)
27.7 (6.7, 114.3)
16.7 (4.0, 68.8)
11.3 (2.7, 47.6)
5.3 (1.2, 23.2)
Referent
*Age-specific tachypnea = $50/min if ,12 months; $40/min if 1–4 years; .24/min if 5–9 years; .22/min if 10–14 years; .20/min if $15 years.
doi:10.1371/journal.pone.0015098.t002
Figure 2. The percentage of patients with RSV infections per total patients tested by month and year among enrolled patients from
SaKaeo (solid black line) and Nakhom Phanom (solid blue line) Provinces, September 1, 2003 – December 31, 2007.
doi:10.1371/journal.pone.0015098.g002
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perspective with other commonly recognized causes of pneumo-
nia. Given the recognized global burden of pneumonia, especially
among children, the information from this study should inform
planning for pneumonia intervention strategies.
To facilitate comparison of our rates with other reports that
capture all hospitalized RSV infections (pneumonia, bronchiolitis,
etc), we estimated the number of RSV acute lower respiratory
tract infections that we missed by limiting our enrollment to
patients who had a chest radiograph within 48 hours of admission
and added these patients to our incidence estimates. The
proportion of RSV infections among hospitalized children aged
,5 years who met the case definition for acute lower respiratory
tract illness but did not have a chest radiograph was 11% (HC
Baggett, personal communication). Combining patients with and
without a chest radiograph our estimated rate of hospitalized RSV
acute lower respiratory tract infection among children ,5 years
would be 883/100,000. This crude estimation is consistent with
rates for RSV-associated hospitalizations and severe disease
among children aged ,5 years reported in a recently published
system review [5].
Prevention and treatment of childhood pneumonia are
important components of the vision of the Global Action Plan
for the Prevention and Control of Pneumonia (GAPP) [21].
However, at this time there is no effective and safe vaccine that
prevents RSV infection in children and there are no proven
treatment modalities. Available prophylactic measures against
RSV, including palivizumab, are very expensive and only
recommended for children at the highest risk for severe RSV
disease[22]. New interventions to prevent and treat RSV illness
could reduce hospitalizations for radiographically-confirmed
pneumonia by up to 22% among Thai children ,5 years of age
and reduce at least a similar proportion of hospitalizations for
other RSV lower respiratory tract illness.
We demonstrated annual peaks in RSV circulation occurring
between July and October in Thailand. Patients admitted to a
hospital with lower respiratory tract illness during these months
were more likely to have RSV infection compared to patients with
a negative RSV test. These peak months are similar to reports
from other countries with tropical and subtropical climates[3] and
other reports from Thailand[23] and correspond to the rainy
season.
Unlike previous reports[24,25,26], we found no differences in
severity of illness among patients with RSV group A and B
infections. However, our analysis was limited by small numbers.
We were unable to evaluate correlations between RSV load in
nasopharyngeal specimens and severity, as reported by others
[27]. We found more RSV group B infections among elderly
adults than group A. Clinical studies from one candidate vaccine
among the elderly, PFP-2 (purified fusion protein), found lower
neutralizing titers to group B viruses compared to group A [28].
Our results are limited by some potential biases. We likely
underestimated the incidence of hospitalized RSV infections. We
did not enroll hospitalized patients who met the clinical case
definition for acute lower respiratory illness but did not have a
chest radiograph ordered within 48 hours of admission; we may
have missed cases of bronchiolitis. Also, serology was performed
for a limited time in one province but added a substantial number
of cases during that time period. The lack of serology testing for
the remainder of the study period likely reduced the number of
RSV infections that we detected. This is especially true for older
children and adults where approximately 50% of infections were
only detected by serology when both RT-PCR and serology were
performed. We did not adjust for the lack of serology in later years
due to the small number of older children and adults who had
both serology and RT-PCR performed. Very young children and
very ill patients were less likely to enroll in the etiology study (H.
Baggett, personal communication). Thus, we may have underes-
timated infections among children ,6 months of age, and we
likely underestimated the number of deaths, especially pediatric
deaths.
The burden of hospitalized RSV-associated pneumonia and
other RSV-associated lower respiratory tract illness among
children ,5 years was substantial in rural Thailand. Efforts to
inexpensively and effectively prevent and treat RSV infection in
children ,5 years of age, including development of effective
vaccines and treatment modalities could substantially reduce the
global number of pediatric pneumonias and respiratory hospital-
izations[21].
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